CeriBell, Inc. (CBLL) Stock Analysis & Investment Frameworks
CeriBell, Inc. (CBLL) stock analysis on Invetso. Review CeriBell, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
CeriBell, Inc. Company Overview
- Exchange: NASDAQ Global Select
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
CeriBell, Inc. Key Financial Metrics
- Market Cap: $1.03B
- Revenue: $89.06M
- ROE: -54.53%
- ROIC: -54.37%
- Dividend Yield: N/A
About CeriBell, Inc.
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.